The Cumming Global Centre @TheDohertyInst@UniMelb is recruiting global research leaders to accelerate pandemic therapeutic development. 7-year research packages. Real impact. Real support.
Apply now: https://t.co/5W2DvDzaoQ
Join the Cumming Global Centre to shape the future of pandemic response! We're hiring full-time researchers across @UniMelb faculties incl. @TheDohertyInst, Science, MDHS & Engineering. Help advance life-saving therapeutics. Apply now: https://t.co/5W2DvDzIeo
(1/5) We are closer than ever to a future without HIV – our leaders must rise to the occasion.
As World Aids Day approaches – 40 years after HIV’s discovery – experts urge world leaders not to pull back from the forgotten pandemic.
https://t.co/FSF9jH3fj6
Proud to see this paper from the lab out today @Nature showing how rifaximin use is driving dapto-R in VRE. Many years of work, great multi-disciplinary collaborations. Led by @adriannamturner and Glen Carter
@TheDohertyInst
@UniMelbMDHS
@Austin_Health
https://t.co/UTfCGiuPqc
The 25th International AIDS Conference has officially come to an end. Thank you for taking part in #AIDS2024! 🙏
Together, we have shone a spotlight on #HIV, ensuring that we #PutPeopleFirst in the global HIV response!
We look forward to seeing you at #HIVR4P2024 in October!
We're excited to welcome @BGrinsztejn as our new IAS President!
Her dedication to the advancement of HIV science, advocacy and support for marginalized communities inspires us all. #AIDS2024
“I’ve been awed by the power of our global #HIV community—vibrant, bold, diverse, and resilient. We will increasingly rely on these characteristics to tackle our challenges.” – New @iasociety President @BGrinsztejn 🇧🇷 #AIDS2024
A heartfelt thank you to @iasociety President and #AIDS2024 International Co-Chair @ProfSharonLewin 🇦🇺 for your remarkable leadership, passion, and dedication throughout the past two years of your IAS Presidency!
Happy 20th birthday to @jiasociety! 🎉
And special thanks to the Editors-in-Chief, @annettesohnBKK and Kenneth Mayer, whose tireless dedication ensures that the open-access journal continues to serve the #HIV research community at large.
🙌 We have reached the final day of AIDS 2024! A full programme of community-led innovations & interventions & the latest science leads up to the rapporteur report back & closing sessions.
👓 Take a look at today’s Daily Digest to get the inside scoop: https://t.co/UnNGHHTh6U
🚀 Day 4 of #AIDS2024 is kicking off! There is a full day of sessions & activities ahead. Make the most of the last day of the Global Village & poster exhibition!
📨 Catch up on yesterday’s action & see what to expect today in this morning’s Daily Digest: https://t.co/AQseHPFVJ0
▶️ Françoise Barre-Sinoussi accepts the IAS President’s Award at #AIDS2024.
The award recognizes the achievements of an individual who demonstrates a history of leadership and excellence as a pioneer or advocate at the forefront of the response to #HIV and AIDS. #AIDS2024
#AIDS2024 International Co-Chair @ProfSharonLewin 🇦🇺 opens the Co-Chairs' Choice session, featuring leading abstract presentations in the field of #HIV.
📊 Today at #AIDS2024, Past IAS President @LindaGailBekker presents full results from PURPOSE 1 trial. The results confirm #lenacapavir demonstrated 100% efficacy for #HIV prevention in cisgender women.
Read IAS President & AIDS 2024 Int'l Co-Chair @ProfSharonLewin's statement.
🇩🇪 Guten Morgen! We had a packed day yesterday with #AIDS2024 well and truly underway, and have another exciting one in store for day 3.
📨 Check out what to expect today and catch up on yesterday’s highlights in a new Daily Digest! https://t.co/Tzo6Ua8hMF
Day 4 of #AIDS2024
Slide 1: Some of the 32 Global Young Leaders recognized by the International AIDS Society (IAS) in a picture with Prof. @ProfSharonLewin (President, @iasociety).
Slide 2: Networking session between Young Leaders & the Leadership of IAS.
#PutPeopleFirst